呼吸之外:对全球慢性阻塞性肺病指南的系统审查,用于疼痛管理
Kaelee Brockway1, Shakeel Ahmed2
1University of St. Augustine for Health Sciences, 901 W. Walnut Hill Ln, Ste 210, Irving, TX, USA.
Respiratory medicine
|February 13, 2024
概括
慢性阻塞性肺病 (COPD) 的疼痛管理建议差异很大,缺乏基于证据的调整. 最佳的疼痛管理需要直接和间接地解决疼痛,改善COPD患者的转诊.
科学领域:
- 肺部医学 肺部医学
- 疼痛管理 疼痛管理
- 临床实践指南 临床实践指南
背景情况:
- 慢性阻塞性肺病 (COPD) 患者经常经历疼痛作为症状和并发症.
- 目前的临床实践指南 (CPG) 缺乏关于COPD疼痛管理策略的全面评估.
研究的目的:
- 更新关于COPD疼痛管理的证据.
- 评估CPG中的疼痛管理建议与最佳实践的一致性.
- 倡导改善COPD患者的疼痛管理.
主要方法:
- 在多个数据库和灰色文献中系统地搜索关于稳定的COPD的CPG.
- 纳入标准侧重于在线可从知名组织获得的CPG.
- 分析涉及疼痛相关术语的频率计数和疼痛管理建议的提取.
主要成果:
- 在审查的32个CPG中,有24个提到"疼痛",其中13个提供了具体的治疗建议.
- 常见的建议包括阿片类药物,药理管理,进一步评估和外科干预.
- 有限的CPG涉及息护理,咳管理或补充疗法,如按摩和放松.
结论:
- 在COPD CPG中对疼痛管理的建议是不一致的,不基于证据.
- 必须在COPD患者治疗疼痛,不管它与疾病有直接或间接的关系.
- 标准化疼痛管理和整合向专业提供者的转诊对于改善患者的治疗结果至关重要.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.8K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206